Cell types Sources Advantages Disadvantages Delivery Animal model Outcome Clinical application Mechanism References Skeletal myoblast Skeletal muscle Contractile, highly resistant to ischemia, large volume, autologous Arrythmia, poor coupling with host tissue Intramyocardial injection, intracoronary infusion Rat, sheep LVEF
EDV
LVSP
intracoronary infusion Myogenesis Paracrine effect [41 –43 ] Embryonic stem cell-derived CMs Embryo Less tumorigenesis, contractile cells Ethical issue Purification Intramyocardial injection Mouse, Rat, Monkey LVEF
EDV
, Wall thickness
N.A Myogenesis Paracrine effect [30 , 44 ] Bone marrow mononuclear cells Bone marrow Autologous, large quantity No myogenesis Intramyocardial injection or intracoronary infusion Rat, Canine, Pig LVEF
LVEF
0–8.1% Paracrine effect [45 –48 ] Mesenchymal stem cells Bone marrow, cord blood, adipose tissue Differentiate to CMs Paracrine effects Autologous Large quantity Low differentiation rate Intracoronary infusion Intramyocardial injection Rat, Pig LVEF
, EDV
, ESV
LVEF
12%, intracoronary Myogenesis Paracrine effect [49 –51 ] VSELs Bone marrow Pluripotent as embryonic stem cell Autologous Small quantity Intracoronary delivery, Intramyocardial injection Mice LVEF
Wall thickness
N.A Myogenesis Paracrine effect [52 ] Cardiac Stem cells Heart muscle Contractile Paracrine effect Autologous Small quantity Cardiac biopsy or surgical sampling Intracoronary infusion, intramyocardial injection Mice, Rat LVEF
; Wall thickness
Yes Myogenesis Paracrine effect [26 ] iPSC Dermal fibroblast Pluripotent, can differentiate to CMs Autologous Large quantity Gene transfer Tumorigenesis Intramyocardial injection LVEF
EDV
ESV
Cell differentiate in vitro and in vivo to CMs N.A Myogenesis Paracrine effect [53 ]